-
Xtant Medical Holdings (XTNT) Tops Q4 EPS by 1c ; Offers Guidance
-
Craig-Hallum lowers PT on Xtant Medical (XTNT) on expected EBITDA margin compression
-
Xtant Medical receives $10.7 million from Companion Spine deal completion
-
Xtant Medical launches nanOss Strata synthetic bone graft product
-
Xtant Medical (XTNT) PT Lowered to $1.50 at BTIG
-
Xtant Medical Holdings (XTNT) Tops Q3 EPS by 2c
-
Xtant Medical launches CollagenX for surgical wound closure
-
Xtant Medical Holdings (XTNT) Tops Q2 EPS by 3c, raises guidance
-
Companion Spine to acquire Paradigm Spine assets from Xtant Medical
-
Xtant Medical to sell spinal implant assets to Companion Spine for $19.2M
-
Xtant Medical Holdings (XTNT) Announces the Launch of OsteoFactor Pro
-
Xtant Medical Holdings (XTNT) Tops Q1 EPS by 1c, provides guidance
-
Xtant Medical Holdings (XTNT) Files for 73.11M Share Offering by Selling Stockholders
-
Xtant Medical Holdings (XTNT) Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%
-
Xtant Medical (XTNT) PT Lowered to $2 at BTIG
-
Xtant Medical Holdings (XTNT) Misses Q4 EPS by 1c
-
Xtant Medical Holdings (XTNT) Misses Q3 EPS by 2c
-
Xtant Medical (XTNT) PT Lowered to $1.50 at Craig-Hallum
-
Xtant Medical Holdings (XTNT) files for 7.81M Share Offering by Selling Stockholders

